Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 1/20 | 0.51 |
| ▸ | FNTA | P49354 | 8/20 | 0.51 |
| ▸ | FNTB | P49356 | 8/20 | 0.51 |
| ▸ | PGGT1B | P53609 | 6/20 | 0.51 |
| ▸ | DPP4 | P27487 | 1/20 | 0.50 |
| ▸ | DPP8 | Q6V1X1 | 1/20 | 0.50 |
| ▸ | DPP9 | Q86TI2 | 1/20 | 0.50 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.47 |
| ▸ | BLM | P54132 | 1/20 | 0.47 |
| ▸ | PMP22 | Q01453 | 1/20 | 0.47 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.47 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5970446 | 1.00 | LMNA (0.51) | LMNAFNTAFNTBPGGT1BDPP4 | |
| SCHEMBL29592643 | 0.96 | FNTA (0.48) | LMNAFNTAFNTBPGGT1BDPP4 | |
| SCHEMBL30591103 | 0.96 | FNTA (0.48) | LMNAFNTAFNTBPGGT1BDPP4 | |
| SCHEMBL5970877 | 0.94 | FNTA (0.48) | LMNAFNTAFNTBPGGT1BDPP4 | |
| SCHEMBL2492672 | 0.94 | FNTA (0.48) | LMNAFNTAFNTBPGGT1BDPP4 | |
| SCHEMBL29376888 | 0.93 | FNTA (0.46) | LMNAFNTAFNTBPGGT1BDPP4 | |
| SCHEMBL31432555 | 0.92 | FNTA (0.46) | LMNAFNTAFNTBPGGT1BDPP4 | |
| SCHEMBL31157674 | 0.92 | FNTA (0.46) | LMNAFNTAFNTBPGGT1BDPP4 | |
| SCHEMBL30173887 | 0.92 | FNTA (0.46) | LMNAFNTAFNTBPGGT1BDPP4 | |
| SCHEMBL8749214 | 0.92 | FNTA (0.46) | LMNAFNTAFNTBPGGT1BDPP4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 69 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-117618299-A | Pleurotus rhodochrous mycelium metabolite, preparation method and application thereof | 福建百想生物科技有限公司 | 2024-03-01 | — | — | CN | claimed |
| CN-116813690-A | Selective sulfonation of benzodiazepine derivatives | 伊缪诺金公司 | 2023-09-29 | — | — | CN | claimed |
| CN-106455664-A | Composition with high content of cyclic dipeptide | 三得利控股株式会社 | 2017-02-22 | — | — | CN | claimed |
| CN-106456633-A | Sugar metabolism improving agent | 三得利控股株式会社 | 2017-02-22 | — | — | CN | claimed |
| EP-3129909-A1 | SMALL MOLECULE BIOCHEMICAL PROFILING OF INDIVIDUAL SUBJECTS FOR DISEASE DIAGNOSIS AND HEALTH ASSESSMENT | Metabolon, Inc. (US) | 2017-02-15 | — | — | EP | claimed |
| WO-2016124574-A1 | DIAGNOSTIC TOOLS FOR ALZHEIMER'S DISEASE | PHARNEXT (FR) | 2016-08-11 | — | — | WO | claimed |
| WO-2015157407-A1 | SMALL MOLECULE BIOCHEMICAL PROFILING OF INDIVIDUAL SUBJECTS FOR DISEASE DIAGNOSIS AND HEALTH ASSESSMENT | METABOLON, INC. (US) | 2015-10-15 | — | — | WO | claimed |
| EP-2454950-B1 | ONION EXTRACT, AND PROCESS FOR PRODUCTION THEREOF | TAKASAGO PERFUMERY CO LTD (JP) | 2014-09-03 | — | — | EP | claimed |
| EP-2454950-A1 | ONION EXTRACT, AND PROCESS FOR PRODUCTION THEREOF | Takasago International Corporation (JP) | 2012-05-23 | — | — | EP | claimed |
| US-20120114827-A1 | ONION EXTRACT, AND PROCESS FOR PRODUCTION THEREOF | TAKASAGO INTERNATIONAL CORPORATION (JP) | 2012-05-10 | — | — | US | claimed |
| US-20260117315-A1 | KEY PREDOMINANT SPECIES OF GUT BACTERIA COLONIZING FARM-EXPOSED INFANTS | WISCONSIN ALUMNI RESEARCH FOUNDATION (US) | 2026-04-30 | — | — | US | disclosed |
| US-20250099623-A1 | COMPOSITIONS AND METHODS FOR ENHANCING INTRA-MITOCHONDRIAL PROTEIN TRANSLATION AND OXIDATIVE PHOSPHORYLATION | THE BROAD INSTITUTE, INC. (US) | 2025-03-27 | — | — | US | disclosed |
| US-12259397-B2 | Biomarkers related to organ function | University of Pittsburgh—of the Commonwealth System of Higher Education (US) | 2025-03-25 | — | — | US | disclosed |
| US-20250074942-A1 | COMPOSITIONS AND METHODS FOR COVALENT PEPTIDE-BASED MODULATORS OF HLA-E | CALICO LIFE SCIENCES LLC (US) | 2025-03-06 | — | — | US | disclosed |
| CN-118581067-A | Method for selecting high M6P recombinant proteins | 阿米库斯治疗学公司 | 2024-09-03 | — | — | CN | disclosed |
| US-20070292916-A1 | MUTANT PROTEIN HAVING THE PEPTIDE-SYNTHESIZING ACTIVITY | AJINOMOTO CO., INC. (JP) | 2007-12-20 | — | — | US | disclosed |
| EP-1829968-A1 | MUTANT PROTEIN HAVING PEPTIDE-PRODUCTION ACTIVITY | Ajinomoto Co., Inc. (JP) | 2007-09-05 | — | — | EP | disclosed |
| US-20070190602-A1 | Mutant protein having the peptide-synthesizing activity | AJINOMOTO CO., INC (JP) | 2007-08-16 | — | — | US | disclosed |
| US-20060217321-A1 | Compositions to improve tic disorders | TAIYOKAGAKU CO., LTD. (JP) | 2006-09-28 | — | — | US | disclosed |
| US-20060188976-A1 | Mutant protein having the peptide-synthesizing activity | AJINOMOTO CO. INC (JP) | 2006-08-24 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260117315-A1 | KEY PREDOMINANT SPECIES OF GUT BACTERIA COLONIZING FARM-EXPOSED INFANTS | FABP2, IL5, FZD7 | LMNA 1537/4885FNTA 2666/4885FNTB 1120/4885 |
| US-20250074942-A1 | COMPOSITIONS AND METHODS FOR COVALENT PEPTIDE-BASED MODULATORS OF HLA-E | MICA, CD74, HLA-DRB1 | LMNA 3512/4885FNTA 3629/4885FNTB 2486/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.